NEW YORK, Nov. 5, (GenomeWeb News) - South San Francisco-based Exelixis reported $12.4 million in revenues for the third quarter ending Sept. 30, up over revenues of $10.4 million for the same period in 2002.
The company reported a net loss of approximately $25 million, up over a net loss of $23 million for the third quarter in 2002.
The company had cash, cash equivalents, short-term investments, and restricted cash of approximately $219 million as of Sept. 30, compared to $222 million at December 31, 2002.
Research and development expenses for the quarter ended September 30, 2003 were $32 million compared to $29 million for the same quarter in 2002.